What is Retatrutide? Retatrutide is a next-generation triple-agonist peptide developed to address obesity, type 2 diabetes, and other metabolic conditions. Unlike earlier treatments, Retatrutide simultaneously targets three key hormone receptors — GLP-1, GIP, and glucagon. This triple action enhances metabolism, suppresses appetite, improves insulin response, and boosts energy expenditure, offering a more comprehensive approach to […]